The Surgeon
Volume 8, Issue 1 , Pages 5-8 , February 2010

Health-related quality of life improvement following surgical treatment of primary hyperparathyroidism in a United Kingdom population

Received 14 October 2009 ,Accepted 22 October 2009.

References 

  1. Joborn C, Hetta J, Johansson H, Rastad J, Agren H, Akerstrom G, et al. Psychiatric morbidity in primary hyperparathyroidism. World J Surg. 1988;12(4):476–481
  2. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341(17):1249–1255
  3. McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32(1):40–66
  4. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483
  5. Kosinski M, Keller SD, Ware JE, Hatoum HT, Kong SX. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care. 1999;37(5 Suppl):MS23–MS39
  6. Ware JE, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology. 1999;30(2):550–555
  7. Burney RE, Jones KR, Coon JW, Blewitt DK, Herm AM. Assessment of patient outcomes after operation for primary hyperparathyroidism. Surgery. 1996;120(6):1013–1018[discussion 1018–9]
  8. Burney RE, Jones KR, Peterson M, Christy B, Thompson NW. Surgical correction of primary hyperparathyroidism improves quality of life. Surgery. 1998;124(6):987–991[discussion 991–82]
  9. Sheldon DG, Lee FT, Neil NJ, Ryan JA. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg. 2002;137(9):1022–1026[discussion 1026–8]
  10. Bowling A, Bond M, Jenkinson C, Lamping DL. Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus Survey in Britain, the Health Survey for England and the Oxford Healthy Life Survey. J Public Health Med. 1999;21(3):255–270
  11. Mihai R, Sadler GP. Pasieka's parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism. World J Surg. 2008;32(5):807–814
  12. Greutelaers B, Kullen K, Kollias J, Bochner M, Roberts A, Wittert G, et al. Pasieka Illness Questionnaire: its value in primary hyperparathyroidism. ANZ J Surg. 2004;74(3):112–115
  13. Goyal A, Chumber S, Tandon N, Lal R, Srivastava A, Gupta S. Neuropsychiatric manifestations in patients of primary hyperparathyroidism and outcome following surgery. Indian J Med Sci. 2001;55(12):677–686
  14. Quiros RM, Alef MJ, Wilhelm SM, Djuricin G, Loviscek K, Prinz RA. Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery. 2003;134(4):675–681[discussion 681–73]
  15. Talpos GB, Bone HG, Kleerekoper M, Phillips ER, Alam M, Honasoge M, et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery. 2000;128(6):1013–1020[discussion 1020–11]

 This paper was presented in the 2007 ASGBI Annual Scientific Meeting as an oral presentation. The abstract was published in British Journal of Surgery 2007;94(Suppl. 2):52.

PII: S1479-666X(09)00006-7

doi: 10.1016/j.surge.2009.10.005

The Surgeon
Volume 8, Issue 1 , Pages 5-8 , February 2010